NCT00635778 A Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002) Status COMPLETED Phase PHASE1
NCT00635648 A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066) Status COMPLETED Phase PHASE3
NCT00632931 A Crossover Study to Assess the Effects of Vorinostat (MK0683, SAHA) in Patients With Advanced Cancer (0683-070)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00632502 Neutrophilic Asthma Study With Navarixin (MK-7123, SCH 527123) (MK-7123-017)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00632203 Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) Status TERMINATED Phase PHASE2
NCT00632073 Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241) Status COMPLETED Phase PHASE1
NCT00631657 A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002) Status COMPLETED Phase PHASE3
NCT00631488 A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015) Status COMPLETED Phase PHASE2
NCT00629980 Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis Status COMPLETED Phase PHASE4
NCT00629941 Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis Status COMPLETED Phase PHASE4
NCT00629590 Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis Status COMPLETED Phase PHASE4
NCT00626990 Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00625612 Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease Status COMPLETED Phase PHASE3
NCT00620659 Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015) Status TERMINATED Phase PHASE2
NCT00620113 Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022) Status COMPLETED Phase PHASE2
NCT00619359 Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017) Status COMPLETED Phase PHASE3
NCT00618995 A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED) Status COMPLETED Phase PHASE1